LEADER 02780nam  2200613 a 450 
001 9910796977603321
005 20180314104846.0
010   $a1-4963-8914-X
035   $a(CKB)4100000005043488
035   $a(MiAaPQ)EBC5944616
035   $a(DLC)  2018012516
035   $a(DLC)9781496389138
035   $a(EXLCZ)994100000005043488
100   $a20180313d2018      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aHandbook of targeted cancer therapy and immunotherapy$b[electronic resource] /$feditors, Daniel D. Karp, Gerald S. Falchook
205   $a2nd ed.
210   $aPhiladelphia $cWolters Kluwer$d[2018]
215   $a1 online resource (319 pages)
300   $aIncludes index.
311   $a1-4963-8913-1 
320   $aIncludes bibliographical references and index.
330   $a"The exponential growth of oncology drug development and personalized/targeted therapy in the recent years has presented a challenge to even the most experienced cancer researchers. Many of us struggle to keep up with the hundreds of clinical trials conducted each year. To help with this challenge, we present here the second edition of our concise handbook intended to make the results of clinical trials of targeted cancer treatments and immunotherapy more easily accessible to cancer researchers and clinicians. We are very proud of the reception the first edition received from oncologists, medical staff, students, and even patients, and we are excited about the updated and widely expanded content included in this second edition"--Provided by publisher.
517 3 $aTargeted cancer therapy and immunotherapy
606   $aNeoplasms$xdrug therapy
606   $aMolecular Targeted Therapy$xmethods
606   $aAntineoplastic Agents$xadministration & dosage
606   $aAntineoplastic Agents$xmetabolism
606   $aAntineoplastic Agents, Immunological
606   $aCancer$xChemotherapy
606   $aDrug targeting
606   $aCancer$xTreatment
608   $aHandbooks
615 12$aNeoplasms$xdrug therapy
615 12$aMolecular Targeted Therapy$xmethods
615 22$aAntineoplastic Agents$xadministration & dosage
615 22$aAntineoplastic Agents$xmetabolism
615 22$aAntineoplastic Agents, Immunological
615  0$aCancer$xChemotherapy.
615  0$aDrug targeting.
615  0$aCancer$xTreatment.
676   $a616.99/4061
701   $aKarp$b Daniel D$01546286
701   $aFalchook$b Gerald S$01546287
801  0$bDNLM/DLC
801  1$bDLC
906   $aBOOK
912   $a9910796977603321
996   $aHandbook of targeted cancer therapy and immunotherapy$93801756
997   $aUNINA